Ceryvyn Therapeutics Ltd CKDXF
Trading Information
- Previous Close Price
- $0.01
- Day Range
- $0.01–0.01
- 52-Week Range
- $0.01–0.01
- Bid/Ask
- $0.00 / $0.01
- Shares Outstanding
- 1.37B
- Market Cap
- $13.17M
- Volume/Avg
- 5,455 / —
Key Statistics
- Price/Earnings (Normalized)
- 0.31
- Price/Sales
- —
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Dividend Payment Schedule
- —
- Total Yield
- —
Company Profile
Ceryvyn Therapeutics Ltd is an Australian biotechnology company developing a biologic therapy for the rare disease LAM (lymphangioleiomyomatosis). It is engaged in the investigation of CYV-101 as a potential treatment for Lymphangioleiomyomatosis (LAM). It operates in one segment, being the biotechnology and healthcare industry in Australia.
- Sector
- Healthcare
- Industry
- Biotechnology
- Stock Style Box
- Small Value
- Total Number of Employees
- 10
- Website
- https://www.ceryvyn.com
Valuation
|
Metric
|
CKDXF
|
|---|---|
Price/Earnings (Normalized) | 0.31 |
Price/Book Value | 0.72 |
Price/Sales | — |
Price/Cash Flow | — |
Price/Earnings
CKDXF
Financial Strength
|
Metric
|
CKDXF
|
|---|---|
Quick Ratio | 13.43 |
Current Ratio | 13.78 |
Interest Coverage | 30.77 |
Quick Ratio
CKDXF
Profitability
|
Metric
|
CKDXF
|
|---|---|
Return on Assets (Normalized) | 137.52% |
Return on Equity (Normalized) | — |
Return on Invested Capital (Normalized) | 177.67% |
Return on Assets
CKDXF
Biotechnology Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Vertex Pharmaceuticals Inc
VRTX
| LOCK|J#C&@% | LOCK|b<&#& | $133B | |||
| Moderna Inc
MRNA
| LOCK|DG#BHf | LOCK|?&! | $98B | |||
| Regeneron Pharmaceuticals Inc
REGN
| LOCK|Y!sp>$V | LOCK|PmJw | $83B | |||
| argenx SE ADR
ARGX
| LOCK|PX&#y<f | LOCK|l% | $56B | |||
| BeOne Medicines Ltd ADR
ONC
| LOCK|$R^#&<n | LOCK|l>Y | $45B | |||
| Alnylam Pharmaceuticals Inc
ALNY
| LOCK|<M@V&@< | LOCK|^M%t | $30B | |||
| Royalty Pharma PLC Class A
RPRX
| LOCK|^J@Z!^> | LOCK|mKsS | $28B | |||
| Incyte Corp
INCY
| LOCK|<CYW#Z | LOCK|@CX | $23B | |||
| BioNTech SE ADR
BNTX
| LOCK|wp>BY>^ | LOCK|V> | $23B | |||
| Jazz Pharmaceuticals PLC
JAZZ
| LOCK|#k%?>> | LOCK|k>V | $14B |
United States